This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

SCRS Committed To Ensuring Its Members Are Well Informed.

ROCKVILLE, Md., Feb. 26, 2013 /PRNewswire/ -- The Society for Clinical Research Sites (SCRS) announced today to its growing membership of nearly 300 member companies in 11 different countries that the hour-long monthly webinars will be included as a member benefit.  The two monthly webinars series focus on Good Clinical Practice (GCP) and Good Business Practice (GBP). 

Christine Pierre, President of SCRS, commented, "Our monthly webinars have been an incredible value to registered attendees; however, when the idea to include including this nearly $2,000  annual value was brought to the Leadership Council, a unanimous decision was made to include the webinar series as a member benefit.  SCRS is a partner in the research ecosystem, and is committed to doing our part to address the issues that hinder the progress in our industry.  Knowledge is the first essential building block needed for our members to ensure human subject protection and gain the elements needed to run a successful research site.  We are thrilled to be offering to our global community the opportunity to participate in these leading edge programs as part of their basic membership. Our member company's involvement extends to all their employees, making our reach impactful."

SCRS has already realized the benefit of this decision by the Leadership Council and is excited to see nearly 2000 attendees participate in the first webinar offered through the new direction of this program.  The first webinar of the series was presented by Doug Peddicord, Ph. D. Executive Director of ACRO and Ann Waldo, JD, CIPP, Partner, Wittie, Letsche & Waldo on the newly released final rule of HIPAA and was entitled " The HIPAA "Omnibus" Rule – What's In Store For Sites."

About SCRS

SCRS is the trade association representing the global clinical research sites.  Through the society, sites will become active partners in industry-wide dialogues focused on improving the clinical research enterprise.  SCRS has a mission of advocating on behalf of its members, connecting sites and other stakeholders to build a purposeful community, educating sites and the industry to create a foundation for informed action, and mentoring sites to help sustain and build a strong site foundation.  Membership in SCRS is open to clinical research sites and companies that sponsor or support the work conducted at sites.  Visit


1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $92.69 -0.59%
FB $119.49 1.43%
GOOG $711.11 1.40%
TSLA $214.93 1.61%
YHOO $37.23 0.79%


Chart of I:DJI
DOW 17,740.63 +79.92 0.45%
S&P 500 2,057.14 +6.51 0.32%
NASDAQ 4,736.1550 +19.0610 0.40%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs